Froome Salbutamol case moves forward - reports

Froome Salbutamol case moves forward - reports

The International Cycling Union (UCI) has reportedly advanced Chris Froome's defence for having excessive levels of the asthma medication Salbutamol in his system during the 2017 Vuelta a España to the next level.

Read on Cycling Central


More Like This

Card image cap

Expert on new Salbutamol study: ‘Not a game-changer’ for Froome case

View
Card image cap

Chris Froome's salbutamol defence boosted by scientific study

View
Card image cap

Chris Froome describes latest reports on salbutamol case as ‘fake news’

View
Card image cap

Report: Tour may deny Froome entry if case unresolved

View
Card image cap

ASO reportedly considering barring Chris Froome from this year's Tour de France

View
Card image cap

Research paper raises questions about Salbutamol tests, may aid Froome’s defence

View
Card image cap

What the newest salbutamol study means for Froome

View
Card image cap

Chris Froome in danger of being blocked from Tour de France

View
Card image cap

Brailsford: I'm constantly thinking, 'Am I the right person to support the team?'

View
Card image cap

ASO moving to block Chris Froome's Tour de France defence

View